Bristol-Myers Squibb
BMY
BMY
2,464 hedge funds and large institutions have $91.5B invested in Bristol-Myers Squibb in 2024 Q4 according to their latest regulatory filings, with 367 funds opening new positions, 923 increasing their positions, 908 reducing their positions, and 108 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.4% more ownership
Funds ownership: 76.11% → 78.5% (+2.4%)
2% more repeat investments, than reductions
Existing positions increased: 923 | Existing positions reduced: 908
0% more call options, than puts
Call options by funds: $1.75B | Put options by funds: $1.75B
Holders
2,464
Holding in Top 10
39
Calls
$1.75B
Puts
$1.75B
Top Buyers
| 1 | +$1.02B | |
| 2 | +$679M | |
| 3 | +$617M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$330M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$212M |
Top Sellers
| 1 | -$782M | |
| 2 | -$719M | |
| 3 | -$435M | |
| 4 |
Two Sigma Investments
New York
|
-$262M |
| 5 |
Amundi
Paris,
France
|
-$151M |